Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 81,336 |
|
|||||
| News | - | ||||||
| Day High | 0.4305 | Low High |
|||||
| Day Low | 0.42 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cadrenal Therapeutics Inc | CVKD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0159 | 3.75% | 0.4395 | 18:01:22 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.4236 | 0.42 | 0.4305 | 0.4305 | 0.4236 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 242 | 81,336 | $ 0.4249088 | $ 34,560 | - | 0.36 - 3.14 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:57:07 | formt | 100 | $ 0.4395 | USD |
Cadrenal Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.88M | 16.01M | - | 0 | -8.36M | -0.52 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cadrenal Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CVKD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.4105 | 0.44 | 0.396 | 0.4175264 | 66,951 | 0.029 | 7.06% |
| 1 Month | 0.638 | 0.638 | 0.36 | 0.424791 | 506,495 | -0.1985 | -31.11% |
| 3 Months | 1.26 | 1.60 | 0.36 | 0.6796315 | 325,224 | -0.8205 | -65.12% |
| 6 Months | 0.4767 | 2.17 | 0.36 | 0.8807907 | 273,202 | -0.0372 | -7.80% |
| 1 Year | 1.37 | 3.14 | 0.36 | 1.29 | 246,203 | -0.9305 | -67.92% |
| 3 Years | 5.71 | 6.75 | 0.36 | 1.67 | 241,231 | -5.27 | -92.30% |
| 5 Years | 5.71 | 6.75 | 0.36 | 1.67 | 241,231 | -5.27 | -92.30% |
Cadrenal Therapeutics Description
| Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib. |
